Outcomes in patients with atrial fibrillation with and without heart failure on oral anticoagulants: a multicenter retrospective cohort study
Xiaomin Dong, Shuyi Wu, Xinhai Huang, Yanxian Lan, Cuifang You, Shuzheng Jiang, Jinhua Zhang · 2026
Read Outcomes in patients with atrial fibrillation with and without heart failure on oral anticoagulants: a multicenter retrospective cohort study by Xiaomin Dong, Shuyi Wu, Xinhai Huang, Yanxian Lan, Cuifang You, Shuzheng Jiang, Jinhua Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13474917.txt.
Description
Dong and co-authors compared outcomes for patients with atrial fibrillation, an irregular heartbeat, who also did or did not have heart failure, in a 2026 study across four Chinese hospitals. All 4,878 patients, enrolled between January 2019 and August 2023, took blood-thinning tablets to prevent strokes after discharge. The team split them into 2,371 patients with heart failure and 2,507 without, then followed them for a median of 19 months.
Heart failure came with a higher risk of death from any cause, at an adjusted odds ratio of 1.414 against the group without failure. Bleeding, clots, and stroke risks, by contrast, showed no clear difference between the groups once other factors were taken into account. In a matched subgroup of heart failure patients, those on rivaroxaban died less often than those on warfarin, with an odds ratio of 0.619, though the authors urge caution given the study design.
Catalog record
| CREATOR | Xiaomin Dong, Shuyi Wu, Xinhai Huang, Yanxian Lan, Cuifang You, Shuzheng Jiang, Jinhua Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |